CVS Health Shares Boosted by Calydon Capital

Calydon Capital increased its stake in CVS Health by 85.9% in the 3rd quarter.

Mar. 15, 2026 at 10:37am

Got story updates? Submit your updates here. ›

Calydon Capital, an investment management firm, increased its holdings in CVS Health Corporation (NYSE:CVS) by 85.9% in the 3rd quarter, according to a recent disclosure with the Securities and Exchange Commission. The fund now owns 96,416 shares of the pharmacy operator's stock, making it the 23rd largest holding in Calydon Capital's portfolio.

Why it matters

The increase in Calydon Capital's stake in CVS Health signals the firm's confidence in the pharmacy operator's growth prospects. As one of the largest healthcare companies in the United States, CVS Health's performance is closely watched by investors and analysts.

The details

Calydon Capital purchased an additional 44,557 shares of CVS Health during the 3rd quarter, bringing its total holdings to 96,416 shares. The shares were valued at $7,269,000 as of the fund's most recent SEC filing. CVS Health makes up 1.2% of Calydon Capital's investment portfolio, making it the 23rd largest holding.

  • Calydon Capital increased its stake in CVS Health during the 3rd quarter of 2026.

The players

Calydon Capital

An investment management firm that has increased its stake in CVS Health Corporation.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and health care solutions.

Got photos? Submit your photos here. ›

The takeaway

The increase in Calydon Capital's stake in CVS Health suggests the firm sees significant growth potential in the healthcare company, which could signal positive news for CVS Health's future performance.